Although there was no overlap between the merged genes in gastric cancer and gastritis (except for NR0B2), the GO results suggest that NR0B2 and its co-expressed genes participate in lipid metabolic and oxidation-related processes in gastric cancer and gastritis. The gene discussed is NR0B2; the disease is gastritis.